Extrahepatic Mets after Liver Transplantation for HCC liver transplantation for patients with recurrent hepatocellular car- cinoma. Clin Transplant 2005;19:175-80. 8. Llovet J, Schwartz M, Mazzaferro V. Resection and liver trans- plantation for hepatocellular carcinoma. Semin Liver Dis 2005; 25:181-200. 9. Pérez-Saborido B, de los Galanes SJ, Menéu-Díaz JC, Romero CJ, Elola-Olaso AM, Suárez YF, et al. Tumor recurrence after liv- er transplantation for hepatocellular carcinoma: recurrence path- way and prognostic factors. Transplant Proc 2007;39:2304-7. 10. Vivarelli M, Cucchetti A, Piscaglia F, La Barba G, Bolondi L, Ca- vallari A, et al. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of im- munosuppression. Liver Transpl 2005;11:497-503. 11. Escartin A, Sapisochin G, Bilbao I, Vilallonga R, Bueno J, Cas- tells L, et al. Recurrence of hepatocellular carcinoma after liver transplantation. Transplant Proc 2007;39:2308-10. 12. Poon RT, Fan ST, O’Suilleabhain CB, Wong J. Aggressive man- agement of patients with extrahepatic and intrahepatic recurrences of hepatocellular carcinoma by combined resection and locore- gional therapy. J Am Coll Surg 2002;195:311-8. 13. Seong J. Challenge and hope in radiotherapy of hepatocellular carcinoma. Yonsei Med J 2009;50:601-12. 14. Park JS, Yoon DS, Kim KS, Choi JS, Lee WJ, Chi HS, et al. What is the best treatment modality for adrenal metastasis from hepato- cellular carcinoma? J Surg Oncol 2007;96:32-6. 15. Lee SS, Morgenstern L, Phillips EH, Hiatt JR, Margulies DR. Splenectomy for splenic metastases: a changing clinical spectrum. Am Surg 2000;66:837-40. Yonsei Med J http://www.eymj.org Volume 52 Number 1 January 2011 203